Ponatinib: Experimental Drug Effective In Curbing Chronic Leukemia In Study
Category: WELLNESS
Ariad is also testing the drug in newly diagnosed CML patients. Final results from that trial are expected at the end of
By Reuters, Reuters, 2012-12-09